Literature DB >> 21570194

Macrocyclic lactone resistance in Dirofilaria immitis.

Catherine Bourguinat1, Kathy Keller, Aron Bhan, Andrew Peregrine, Timothy Geary, Roger Prichard.   

Abstract

Microfilariae were isolated from a Katrina rescue dog that remained microfilariaemic despite successful adulticidal treatments and repeated treatment with high doses of macrocyclic lactones (MLs). The microfilariae were genotyped at two P-glycoprotein single nucleotide polymorphic sites which had been found to correlate with reduced sensitivity to MLs. The genetic polymorphism (GG-GG), previously found to be associated with insensitivity to MLs in vitro, was present at a frequency of 45.3% in microfilariae that survived repeated treatments with high doses of ML anthelmintics. The data show phenotypic and genotypic evidence of ML resistance in Dirofilaria immitis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570194     DOI: 10.1016/j.vetpar.2011.04.012

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  38 in total

1.  Heartworm resistance.

Authors:  Carlton Gyles
Journal:  Can Vet J       Date:  2011-12       Impact factor: 1.008

2.  Comparative analysis of the secretome from a model filarial nematode (Litomosoides sigmodontis) reveals maximal diversity in gravid female parasites.

Authors:  Stuart D Armstrong; Simon A Babayan; Nathaly Lhermitte-Vallarino; Nick Gray; Dong Xia; Coralie Martin; Sujai Kumar; David W Taylor; Mark L Blaxter; Jonathan M Wastling; Benjamin L Makepeace
Journal:  Mol Cell Proteomics       Date:  2014-06-23       Impact factor: 5.911

3.  Dogs: The riddle of resistance.

Authors:  Michael Eisenstein
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

Review 4.  Human and animal dirofilariasis: the emergence of a zoonotic mosaic.

Authors:  Fernando Simón; Mar Siles-Lucas; Rodrigo Morchón; Javier González-Miguel; Isabel Mellado; Elena Carretón; Jose Alberto Montoya-Alonso
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 5.  P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.

Authors:  Anne Lespine; Cécile Ménez; Catherine Bourguinat; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-07       Impact factor: 4.077

Review 6.  Heartworm disease - Overview, intervention, and industry perspective.

Authors:  Sandra Noack; John Harrington; Douglas S Carithers; Ronald Kaminsky; Paul M Selzer
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2021-04-27       Impact factor: 4.077

7.  First analysis of the secretome of the canine heartworm, Dirofilaria immitis.

Authors:  James Geary; Mohamed Satti; Yovany Moreno; Nicole Madrill; Doug Whitten; Selwyn A Headley; Dalen Agnew; Timothy Geary; Charles Mackenzie
Journal:  Parasit Vectors       Date:  2012-07-10       Impact factor: 3.876

Review 8.  A research agenda for helminth diseases of humans: intervention for control and elimination.

Authors:  Roger K Prichard; María-Gloria Basáñez; Boakye A Boatin; James S McCarthy; Héctor H García; Guo-Jing Yang; Banchob Sripa; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

9.  The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets.

Authors:  Christelle Godel; Sujai Kumar; Georgios Koutsovoulos; Philipp Ludin; Daniel Nilsson; Francesco Comandatore; Nicola Wrobel; Marian Thompson; Christoph D Schmid; Susumu Goto; Frédéric Bringaud; Adrian Wolstenholme; Claudio Bandi; Christian Epe; Ronald Kaminsky; Mark Blaxter; Pascal Mäser
Journal:  FASEB J       Date:  2012-08-13       Impact factor: 5.191

10.  Genetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility.

Authors:  I Jana I Janssen; Jürgen Krücken; Janina Demeler; Marta Basiaga; Sławomir Kornaś; Georg von Samson-Himmelstjerna
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.